Michael Dittmar

Michael Dittmar practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Michael Dittmar's NPI, 1801357439, was assigned on March 27, 2019. Michael Dittmar graduated from University of Colorado School of Medicine in 2019. Michael Dittmar holds California license A178438.

Michael Dittmar's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Michael Dittmar's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Michael Dittmar to 1 more home health agency and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Dittmar practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Michael Dittmar's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Michael Dittmar is board certified in internal medicine by the American Board of Internal Medicine. Michael Dittmar is licensed in California.

Dmand AI lists gastrointestinal infection among the conditions Michael Dittmar treats.

CMS data shows 600 Medicare services from Michael Dittmar across 2 procedure codes in 2024, for 137 Medicare patients. Medicare paid $60,309 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Michael Dittmar in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 70% have cancer. 46% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Dittmar's median patient age at 65, with 49% women.

In 2024, Michael Dittmar wrote 93 Medicare Part D claims for 40 patients. 86% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $204 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Michael Dittmar for performance year 2024, reported as part of a group. Michael Dittmar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Michael Dittmar, published from 2011 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Emergency Medical Services, Algorithms and Blood-Brain Barrier. Michael Dittmar has published most often in PLoS One. Michael Dittmar's most frequent co-authors are Jesus Antonio Araujo, MD, Brian R. Branchford, MD and Neil Goldenberg, MD.

Michael Dittmar graduated from University of Colorado School of Medicine in 2019.

Michael Dittmar is in network with 11 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.